LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage
2025 · 3rd Quarter (July 1 - Sep 30)
TONIX PHARMACEUTICALS HOLDING CORP.
Filed by BURRELL INTERNATIONAL GROUP LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 18, 2025
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- BURRELL INTERNATIONAL GROUP LLC
- Filing UUID
- 6f1d59d9-2cee-416d-ac0b-2b32b7f691b0
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.